Safety and efficacy of recombinant acid alpha-glucosidase (rhGAA) in patients with classical infantile Pompe disease: results of a phase II clinical trial. (Q47869064)
Jump to navigation
Jump to search
scientific article published on 26 November 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and efficacy of recombinant acid alpha-glucosidase (rhGAA) in patients with classical infantile Pompe disease: results of a phase II clinical trial. |
scientific article published on 26 November 2004 |
Statements
1 reference
Safety and efficacy of recombinant acid alpha-glucosidase (rhGAA) in patients with classical infantile Pompe disease: results of a phase II clinical trial. (English)
1 reference
Klinge L
1 reference
Straub V
1 reference
Neudorf U
1 reference
Schaper J
1 reference
Bosbach T
1 reference
Görlinger K
1 reference
Wallot M
1 reference
Richards S
1 reference
Voit T
1 reference
26 November 2004
1 reference
1 reference
15
1 reference
1
1 reference
24-31
1 reference
Identifiers
1 reference
1 reference